Title(s): RTOG 1122. Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab with or without AMG 386 in Patients with Recurrent Glioblastoma or Gliosarcoma
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): RTOG 1205. Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
